Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hackensack Meridian Center for Discovery and Innovation (CDI) is a premier research institute based in Nutley, New Jersey, dedicated to translating scientific breakthroughs into clinical solutions. Established by Hackensack Meridian Health, the CDI focuses on three main pillars: infectious diseases, cancer, and regenerative medicine. The center operates state-of-the-art laboratories and leverages a multidisciplinary approach to develop novel diagnostics, treatments, and vaccines. Notable achievements include the rapid development of diagnostic tests during the COVID-19 pandemic and advanced research into drug-resistant pathogens like tuberculosis. By bridging the gap between laboratory research and patient care, the CDI aims to accelerate the delivery of personalized medicine and innovative therapies to the bedside.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hackensack Meridian Center for Discovery.